Development of human anti-thymidine kinase antibodies

Anti-Cancer Drugs

Volumn 12, Issue 6, 2001, Pages 555-559

  Voeller, Donna M ^a,b   Parr, Allyson ^a   Allegra, Carmen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Antibody; Thymidine kinase

Indexed keywords

9 AMINOCAMPTOTHECIN; CAMPTOTHECIN; COMPLEMENTARY DNA; NUCLEOSIDE; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; COLON CANCER; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEIOMYOMA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CATALYSIS; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; PEPTIDES; RABBITS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0034927712     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200107000-00010     Document Type: Article

References (4)

1. Antimetabolites
2. Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs
3. Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma
4. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase